Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
Go back to Moderna Adds Chief Operating Officer Role as Company Expands into Oncology| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 203.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $203.46 | 52 Week High | $0.52 | |||
| Open | $203.46 | 52 Week Low | $0.08 | |||
| Day High | $203.46 | P/E | N/A | |||
| Day Low | $203.46 | EPS | $-3.80 | |||
| Volume | 1,726,299 | |||||
